Abstract. The insensitivity of Graves' thyroid to stimulation of cAMP formation by TSH as well as Graves'
Abstract. The insensitivity of Graves' thyroid to stimulation of cAMP formation by TSH as well as Graves' immunoglobulins in vitro is well known. The present study was performed to find out Graves' sera which may induce a final activation i.e. stimulation of T3 release in Graves' thyroid slices despite this insensitivity of tissue and to characterize determinants responsible for the efficiency of those sera. Out of 20 sera from patients with active untreated Graves' disease 6 were found to stimulate T3 release from Graves' thyroid in vitro. These 6 sera were effective in stimulating different Graves' glands, irrespective of pretreatment with propranolol, thiamazole (methimazole) or thiamazole plus iodine. In contrast, a significant response to bTSH was not observed in any Graves' gland. For (Smith & Hall 1974) , to stimulate adenylate cyclase activity (Onaya et al. 1973) and to release T3 from thyroid slices (Atkinson & Kendall-Taylor 1981; Laurberg & Weeke 1975) .
However, there is only little direct evidence that these immunoglobulins are potent stimulators of Graves' thyroid in vitro (Kuzuya et Kendall-Taylor (1981) , which determines the T3 release from thyroid slices. The method has been described in detail previously (Hörmann et T3 (negative control)
The intra-assay variation of the method at half maxi¬ mal stimulation by 5 pooled Graves' sera was 15% (n = 5) and the inter-assay variation 33% (n = 15).
Radioreceptor assayfor TSH binding inhibiting immunoglobulins (TBII) TBII were determined by a radioreceptor assay (TRAK-assay, Fa. Henning) using detergent solubilised porcine TSH receptors according to Shewring 8c Smith (1982) .
We have recently reported on methodological details and clinical application of this assay in a large number of patients (Hörmann et al. 1985 Graves' immunoglobulins has been well documented in several studies (Kuzuya et 
